Yup your right, got a bit trigger happy there in the absence of shortman updates....I expect the same result but will need to look at cumulative.Cheers for pointing it out
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
